MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
125.47%
Quick Ratio
125.47%
Cash Ratio
81.97%
Debt to Asset Ratio
92.48%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Accounts receivable
    • Less accumulated depreciation
    • Others
Liabilities Breakdown
    • Additional paid in capital
    • Accumulated deficit
    • Top-up share obligations
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
17,392
16,379
27,136
11,701
Marketable securities
-
-
-
6,971
Accounts receivable
5,377
5,351
5,546
387
Deposits, current portion
22
1,062
1,093
1,747
Prepaid expenses and other current assets
1,933
1,701
1,309
3,114
Foreign withholding tax receivable
1,899
1,899
1,899
1,899
Total current assets
26,623
26,392
36,983
25,819
Total property and equipment
4,025
4,025
3,904
3,904
Less accumulated depreciation
3,770
3,737
3,663
3,597
Property and equipment, net
255
288
241
307
Operating lease right-of-use asset
2,959
3,318
4,074
4,602
Deposits
628
635
666
667
Restricted cash
154
154
154
153
Other long-term assets
88
90
94
96
Total assets
30,707
30,877
42,212
31,644
Accounts payable
3,747
3,327
3,948
2,348
Accrued expenses
14,883
1,499
1,611
1,871
Research and development contract liability, current portion
0
0
5,335
7,816
Operating lease liabilities, current
1,628
1,562
1,911
2,031
Current portion of long-term debt, net
-
-
0
1,458
Other current payable
960
1,003
689
-
Total current liabilities
21,218
7,391
13,494
15,524
Operating lease liabilities, non-current
1,449
1,878
2,286
2,684
Other long-term payable
-
-
-
190
Top-up share obligations
5,730
-
-
-
Total liabilities
28,397
9,269
15,780
18,398
Common stock, 0.001 par value 300,000,000 shares authorized 5,229,392 and 3,220,707 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
5
3
97
78
Additional paid in capital
529,016
395,249
394,801
383,218
Accumulated other comprehensive loss
-
-
-
1
Accumulated deficit
-526,711
-373,644
-368,466
-370,051
Total stockholders' equity
2,310
21,608
26,432
13,246
Total liabilities and stockholders' equity
30,707
30,877
42,212
31,644
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$17,392K (-36.74%↓ Y/Y)Accounts receivable$5,377K (910.71%↑ Y/Y)Prepaid expenses andother current assets$1,933K (-17.74%↓ Y/Y)Foreign withholding taxreceivable$1,899K (0.00%↑ Y/Y)Deposits, current portion$22K (-95.32%↓ Y/Y)Total property andequipment$4,025K (-7.00%↓ Y/Y)Total current assets$26,623K (-13.68%↓ Y/Y)Operating leaseright-of-use asset$2,959K (-42.18%↓ Y/Y)Deposits$628K (-67.89%↓ Y/Y)Property and equipment,net$255K (-43.83%↓ Y/Y)Restricted cash$154K (0.65%↑ Y/Y)Other long-termassets$88K (-68.90%↓ Y/Y)Less accumulateddepreciation$3,770K (-2.68%↓ Y/Y)Total assets$30,707K (-24.57%↓ Y/Y)Total liabilities andstockholders' equity$30,707K (-24.57%↓ Y/Y)Total liabilities$28,397K (25.94%↑ Y/Y)Total stockholders'equity$2,310K (-87.28%↓ Y/Y)Accumulated deficit-$526,711K (-45.26%↓ Y/Y)Total currentliabilities$21,218K (10.20%↑ Y/Y)Top-up shareobligations$5,730K Operating leaseliabilities, non-current$1,449K (-53.32%↓ Y/Y)Additional paid in capital$529,016K (38.96%↑ Y/Y)Common stock, 0.001 parvalue 300,000,000...$5K (-93.42%↓ Y/Y)Accrued expenses$14,883K (880.43%↑ Y/Y)Accounts payable$3,747K (3.31%↑ Y/Y)Operating leaseliabilities, current$1,628K (-22.99%↓ Y/Y)Other current payable$960K

Cue Biopharma, Inc. (CUE)

Cue Biopharma, Inc. (CUE)